{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T12:21:21Z","timestamp":1784809281635,"version":"3.55.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["arthroplastyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Arthroplasty"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.arth.2023.08.029","type":"journal-article","created":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T11:30:54Z","timestamp":1692012654000},"page":"448-451.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Bisphosphonate Use May be Associated With an Increased Risk of Periprosthetic Hip Fracture"],"prefix":"10.1016","volume":"39","author":[{"suffix":"III","given":"Joseph","family":"Serino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Bailey","family":"Terhune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William E.","family":"Harkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew T.","family":"Weintraub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanford","family":"Baim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig J.","family":"Della Valle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arth.2023.08.029_bib1","doi-asserted-by":"crossref","first-page":"128","DOI":"10.2106\/JBJS.H.00155","article-title":"The epidemiology of revision total hip arthroplasty in the United States","volume":"91","author":"Bozic","year":"2009","journal-title":"J\u00a0Bone Joint Surg Am"},{"key":"10.1016\/j.arth.2023.08.029_bib2","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.arth.2005.02.001","article-title":"Periprosthetic femoral fractures classification and demographics of 1049 periprosthetic femoral fractures from the Swedish National Hip Arthroplasty Register","volume":"20","author":"Lindahl","year":"2005","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2023.08.029_bib3","first-page":"27","article-title":"Mortality after periprosthetic femur fractures","volume":"26","author":"Streubel","year":"2013","journal-title":"J\u00a0Knee Surg"},{"key":"10.1016\/j.arth.2023.08.029_bib4","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.bone.2007.01.003","article-title":"The excess mortality due to periprosthetic femur fracture. A study from the Swedish national hip arthroplasty register","volume":"40","author":"Lindahl","year":"2007","journal-title":"Bone"},{"key":"10.1016\/j.arth.2023.08.029_bib5","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0020-1383(02)00257-7","article-title":"The management of periprosthetic femoral fractures around hip replacements","volume":"34","author":"Tsiridis","year":"2003","journal-title":"Injury"},{"key":"10.1016\/j.arth.2023.08.029_bib6","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.injury.2007.02.048","article-title":"Epidemiology of periprosthetic femur fracture around a total hip arthroplasty","volume":"38","author":"Lindahl","year":"2007","journal-title":"Injury"},{"key":"10.1016\/j.arth.2023.08.029_bib7","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1097\/BOT.0b013e31821b8c28","article-title":"Periprosthetic fractures: epidemiology and Future Projections","volume":"25","author":"Della Rocca","year":"2011","journal-title":"J\u00a0Orthop Trauma"},{"key":"10.1016\/j.arth.2023.08.029_bib8","doi-asserted-by":"crossref","first-page":"189","DOI":"10.11138\/ccmbm\/2017.14.1.189","article-title":"Periprosthetic fractures: epidemiology and current treatment","volume":"14","author":"Capone","year":"2017","journal-title":"Clin Cases Miner Bone Metab"},{"key":"10.1016\/j.arth.2023.08.029_bib9","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1002\/jbmr.2269","article-title":"The recent prevalence of osteoporosis and low bone mass in the United States based on bone mineral density at the femoral neck or lumbar spine","volume":"29","author":"Wright","year":"2014","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.arth.2023.08.029_bib10","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1016\/j.arth.2022.04.010","article-title":"Total joint arthroplasty and osteoporosis: looking beyond the joint to bone health","volume":"37","author":"Wang","year":"2022","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2023.08.029_bib11","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.bone.2006.11.013","article-title":"The incidence of osteopenia and osteoporosis in women with hip osteoarthritis scheduled for cementless total joint replacement","volume":"40","author":"M\u00e4kinen","year":"2007","journal-title":"Bone"},{"key":"10.1016\/j.arth.2023.08.029_bib12","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1177\/1120700019883244","article-title":"Total hip arthroplasty in patients with osteoporosis","volume":"30","author":"Karachalios","year":"2020","journal-title":"Hip Int"},{"key":"10.1016\/j.arth.2023.08.029_bib13","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.arth.2019.03.044","article-title":"Osteoporosis is common and undertreated prior to total joint arthroplasty","volume":"34","author":"Bernatz","year":"2019","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2023.08.029_bib14","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1210\/er.2018-00001","article-title":"Atypical femur fractures: review of epidemiology, relationship to bisphosphonates, prevention, and clinical management","volume":"40","author":"Black","year":"2019","journal-title":"Endocr Rev"},{"key":"10.1016\/j.arth.2023.08.029_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2021.116297","article-title":"Bisphosphonates and the risk of atypical femur fractures","volume":"156","author":"Black","year":"2022","journal-title":"Bone"},{"key":"10.1016\/j.arth.2023.08.029_bib16","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1056\/NEJMoa1916525","article-title":"Atypical femur fracture risk versus fragility fracture prevention with bisphosphonates","volume":"383","author":"Black","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.arth.2023.08.029_bib17","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1056\/NEJM200102013440503","article-title":"Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group","volume":"344","author":"McClung","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.arth.2023.08.029_bib18","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.artd.2022.02.003","article-title":"Bisphosphonates in total joint arthroplasty: a review of their use and complications","volume":"14","author":"McDonald","year":"2022","journal-title":"Arthroplast Today"},{"key":"10.1016\/j.arth.2023.08.029_bib19","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2106\/JBJS.D.01772","article-title":"Effect of bisphosphonates on periprosthetic bone mineral density after total joint arthroplasty. A meta-analysis","volume":"87","author":"Bhandari","year":"2005","journal-title":"J\u00a0Bone Joint Surg Am"},{"key":"10.1016\/j.arth.2023.08.029_bib20","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.arth.2014.01.015","article-title":"Systematic analysis of bisphosphonate intervention on periprosthetic BMD as a function of stem design","volume":"29","author":"Knusten","year":"2014","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2023.08.029_bib21","doi-asserted-by":"crossref","first-page":"569","DOI":"10.3109\/17453674.2015.1041846","article-title":"No effect of risedronate on femoral periprosthetic bone loss following total hip arthroplasty. A 4-year follow-up of 61 patients in a double-blind, randomized placebo-controlled trial","volume":"86","author":"Muren","year":"2015","journal-title":"Acta Orthop"},{"key":"10.1016\/j.arth.2023.08.029_bib22","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.bone.2010.01.377","article-title":"Postoperative use of bisphosphonates and risk of revision after primary total hip arthroplasty: a nationwide population-based study","volume":"46","author":"Thillemann","year":"2010","journal-title":"Bone"},{"issue":"Suppl 3","key":"10.1016\/j.arth.2023.08.029_bib24","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2106\/JBJS.22.00607","article-title":"Commercial claims data sources: PearlDiver and individual Payer databases","volume":"104","author":"Bolognesi","year":"2022","journal-title":"J\u00a0Bone Joint Surg Am"},{"key":"10.1016\/j.arth.2023.08.029_bib25","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3810\/pgm.2010.01.2102","article-title":"Primary care use of FRAX: absolute fracture risk assessment in postmenopausal women and older men","volume":"122","author":"Siris","year":"2010","journal-title":"Postgrad Med"},{"key":"10.1016\/j.arth.2023.08.029_bib26","series-title":"UK: Centre for Metabolic bone Diseases","article-title":"FRAX fracture risk assessment Tool","year":"2011"},{"key":"10.1016\/j.arth.2023.08.029_bib27","doi-asserted-by":"crossref","first-page":"d7222","DOI":"10.1136\/bmj.d7222","article-title":"Association between bisphosphonate use and implant survival after primary total arthroplasty of the knee or hip: population based retrospective cohort study","volume":"343","author":"Prieto-Alhambra","year":"2011","journal-title":"Bmj"},{"key":"10.1016\/j.arth.2023.08.029_bib28","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1007\/s11999-015-4263-4","article-title":"Association of bisphosphonate use and risk of revision after THA: outcomes from a US total joint replacement registry","volume":"473","author":"Khatod","year":"2015","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.arth.2023.08.029_bib29","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.arth.2015.09.005","article-title":"Lower total knee arthroplasty revision risk associated with bisphosphonate use, even in patients with normal bone density","volume":"31","author":"Namba","year":"2016","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2023.08.029_bib30","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00005650-199801000-00004","article-title":"Comorbidity measures for use with administrative data","volume":"36","author":"Elixhauser","year":"1998","journal-title":"Med Care"},{"key":"10.1016\/j.arth.2023.08.029_bib31","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.arth.2019.01.044","article-title":"A\u00a0weighted index of Elixhauser comorbidities for predicting 90-day Readmission after total joint arthroplasty","volume":"34","author":"Goltz","year":"2019","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2023.08.029_bib32","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.arth.2017.08.032","article-title":"Discriminative Ability of Elixhauser's comorbidity measure is Superior to other comorbidity scores for Inpatient adverse outcomes after total hip arthroplasty","volume":"33","author":"Ondeck","year":"2018","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2023.08.029_bib33","first-page":"50","article-title":"Ibandronate and cementless total hip arthroplasty: densitometric measurement of periprosthetic bone mass and new therapeutic approach to the prevention of aseptic loosening","volume":"9","author":"Muratore","year":"2012","journal-title":"Clin Cases Miner Bone Metab"},{"key":"10.1016\/j.arth.2023.08.029_bib34","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1302\/0301-620X.98B4.37201","article-title":"Epidemiology of periprosthetic fracture of the femur in 32 644 primary total hip arthroplasties: a 40-year experience","volume":"98-b","author":"Abdel","year":"2016","journal-title":"Bone Joint Lett J"},{"key":"10.1016\/j.arth.2023.08.029_bib35","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0030-5898(05)70073-0","article-title":"Epidemiology: hip and knee","volume":"30","author":"Berry","year":"1999","journal-title":"Orthop Clin North Am"}],"container-title":["The Journal of Arthroplasty"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883540323008227?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883540323008227?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:46:15Z","timestamp":1760121975000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0883540323008227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S0883540323008227"],"URL":"https:\/\/doi.org\/10.1016\/j.arth.2023.08.029","relation":{},"ISSN":["0883-5403"],"issn-type":[{"value":"0883-5403","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bisphosphonate Use May be Associated With an Increased Risk of Periprosthetic Hip Fracture","name":"articletitle","label":"Article Title"},{"value":"The Journal of Arthroplasty","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arth.2023.08.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}